EIBIR Winter School on Interdisciplinary Biomedical Imaging

17-22 January 2010, Viladrau, Spain.
The main objective of the EIBIR Winter School is to support the interdisciplinary training of technical and clinical PhD students working in the broad area of biomedical imaging. In this first EIBIR Winter School on Interdisciplinary Biomedical Imaging, two key clinical disease areas will be addressed which altogether represent the two leading causes of death worldwide: cardiovascular and oncologic diseases. Each topic will be covered from the perspective of novel methods for biomedical image acquisition, analysis and interpretation as well as from the perspective of computational modeling and interventional planning, where appropriate. The themes will be explored based on the key driving clinical questions as well as from an understanding of the underlying disease mechanisms or pathophysiology.

The faculty will include lecturers with a clinical, biomedical and technical background, from both academia and industry. Reading groups, poster sessions and social activities will be offered.

Target Group
Second- and third-year students pursuing their graduate studies within PhD programs of biomedical engineering, computer science, electrical engineering, physics, medical physics, and medicine. Participants should have a basic understanding of biomedical imaging in terms of acquisition and image analysis and interpretation. Possibility to earn CME credits.

Location
Viladrau/Spain, about 70km from Barcelona, located within the Montseny Natural Park

Application
Via email to This email address is being protected from spambots. You need JavaScript enabled to view it., until October 22nd, 2009 including:

  • Curriculum Vitae including contact details of two referees and current main supervisor
  • Letter of intention
Number of participants admitted: 45 PhD students;

Notification of selected candidates: Before November 15th 2009

Participation fees
EUR 645,- (twin room)
EUR 795,- (single room)
Including attendance of the course, full board accommodation, bus from Barcelona to Viladrau and back, all social activities. Payment of registration fees before December 1st, 2009.

For further information, please visit:
http://www.eibir.org

About EIBIR
The European Institute for Biomedical Imaging Research (EIBIR) is a non-profit limited liability company that was founded in 2006 by the European Society of Radiology (ESR), dedicated to the co-ordination of research.

EIBIR has the aim of co-ordinating and supporting the development of biomedical imaging technologies and the dissemination of knowledge with the ultimate goal of improving diagnosis, treatment and prevention of disease.

The platform supports networking activities in research and is key to spreading good practice, promoting common initiatives and interoperability in the field of biomedical imaging research.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...